Skip to main content
. Author manuscript; available in PMC: 2015 Aug 6.
Published in final edited form as: Lancet. 2014 Aug 6;384(9959):2027–2035. doi: 10.1016/S0140-6736(14)60525-0

Table 4.

All cause and prostate cancer mortality by age at randomization, France excluded.

Intervention arm Control arm Rate Ratios 95% CI P-value
All cause mortality
Deaths (N) Person years Rate per 1000
personyears
Deaths (N) Person years Rate per 1000
personyears
Core age group 15369 825018 18.6 19108 1011192 18.9 1.00 0.98–1.02 0.82
All ages 18251 935185 19.5 21992 1120432 19.6 1.00 0.98–1.02 0.98
Prostate cancer mortality
Age groups (yrs)
<=54 6 64265 0.09 7 62312 0.11 0.84 0.28–2.49 0.75
55–59 114 411834 0.28 174 524314 0.33 0.81 0.93–1.03 0.09
60–64 121 240895 0.50 159 280404 0.57 0.90 0.71–1.15 0.41
65–69 120 172289 0.70 212 2064774 1.03 0.69 0.55–0.87 0.002
70+ 66 45903 1.44 58 46928 1.24 1.17 0.82–1.66 0.40
Core age group 355 825018 0.43 545 1011192 0.54 0.79 0.69–0.91 0.001
All ages 427 935185 0.46 610 1120432 0.54 0.83 0.73–0.94 0.004

Test for heterogeneity: (PC mortality) All ages χ24 = 6.26 p= 0.18 Core age group χ22 = 2.31 p= 0.32